Helus Pharma
Toronto, Ontario, Canada · Biotechnology, Health Care, Manufacturing
Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. The company is advancing patient-centered innovation through clinical excellence to deliver meaningful and durable outcomes that support long-term healing.
Key facts
- Headquarters
- Toronto, Ontario, Canada
- Employees
- Unknown
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- www.helus.com
- Company page
Recent activity at Helus Pharma
Leadership
- Aaron, Chief Operating Officer
- Michael Halstead, Chief Executive Officer
- Michael Cola, Chief Executive Officer
Verified email and direct lines for Helus Pharma’s decision-makers are on Fundz. See plans
Helus Pharma in the news
- Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results - Mon, 06/29/2026 - 07:40 - ir.helus.com (Jun 29, 2026)
- HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq - Business Wire (Jan 05, 2026)
- Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - Tue, 04/28/2026 - 07:30 - ir.helus.com (Apr 28, 2026)
- Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results - Yahoo Finance (Mar 06, 2026)
- Cybin alters state to become Helus Pharma for Nasdaq trip - Fierce Pharma (Dec 19, 2025)
- Helus Pharma Appoints Michael Halstead as Chief Executive Officer - GlobeNewswire (Aug 03, 2026)
- TD Cowen raises Helus Pharma stock price target to $62 on trial timing - Investing.com India (Aug 20, 2026)
- Helus' psychedelic drug DMT 'could help treat depression' - pharmaphorum (Feb 17, 2026)
Companies similar to Helus Pharma
- Mayne Pharma · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- GMP Manufacturing Ltd · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Tirupati Group · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- AbbVie Inc. · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Optimi Health · Biotechnology, Health Care, Manufacturing, Pharmaceutical
About Helus Pharma: questions and answers
What does Helus Pharma do?
Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. The company is advancing patient-centered innovation through clinical excellence to deliver meaningful and durable outcomes that support long-term healing.
Where is Helus Pharma headquartered?
Helus Pharma is headquartered in Toronto, Ontario, Canada.
Who leads Helus Pharma?
Michael Halstead is a Chief Executive Officer at Helus Pharma.
What is the latest news on Helus Pharma?
On Aug 03, 2026, Helus Pharma Appoints Michael Halstead as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy